Showing results (391-400 of 5,019) with videos related to
Sort By:
Pageof 502
Protein Expression and Purification|February 18, 2015
Recombinant expression and characterization of biologically active protein delta homolog 1Tom-Marten Kilian, Annette G Beck-SickingerScandinavian Journal of Infectious Diseases|January 1, 1989
Potentially pathogenic microorganisms in the oral cavity during febrile episodes in immunocompromised patients with haematologic malignanciesO J Bergmann, M Kilian, J EllegaardMobile Genetic Elements|October 13, 2012
The flexible gene pool of Propionibacterium acnesHolger Brüggemann, Hans B Lomholt, Mogens KilianArchives of Public Health = Archives Belges De Sante Publique|August 15, 2022
An examination of the medicalization and pharmaceuticalization processes of anxiety and depressive disorders in Belgium between 2004 and 2013: how may both disorders be intertwined?Van Looy Kilian, Van de Velde SarahJournal of Personality|October 13, 2025
Influence of Agreeableness on Responsiveness: Effort Versus SkillJenna L Kilian, Judith Gere, Jessica LaBudaAmerican Journal of Ophthalmology Case Reports|September 29, 2025
Saloon Door Technique - "open sky" IOL exchange utilising flanged haptic fixation behind a pre-existing Artificial IrisKilian Roth, Konstantin Seiller-Tarbuk, Michael AmonEuropean Psychiatry : the Journal of the Association of European Psychiatrists|January 21, 2025
Utilisation of alcohol-related treatment after a first alcohol use disorder diagnosis in Hamburg, GermanyJakob Manthey, Kilian Huß, Sven Buth, et al.Der Nervenarzt|July 16, 2003
[The impact of the study design and the sampling procedure on the assessment of mental health services]R Kilian, C Roick, M C AngermeyerBehavioural Processes|February 3, 2005
Left hemispheric advantage for numerical abilities in the bottlenose dolphinAnnette Kilian, Lorenzo von Fersen, Onur GüntürkünGesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|April 17, 2004
[Methodolocical issues of naturalistic observational studies on the economic evaluation of neuroleptic treatment for schizophrenic disease]R Kilian, M C Angermeyer, T BeckerPageof 502